# Biofrontera AG (BFRA)

Source: https://www.quantisnow.com/company/BFRA
Generated: 2026-11-16T10:07:52.440Z

- Ticker: BFRA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: biofrontera.com

## About

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

## Latest BFRA news and filings

- 2022-06-02 17:57 UTC [Market Chatter] [Biofrontera AG Says Will Terminate Its U.S. ADS Program](https://www.quantisnow.com/insight/biofrontera-ag-says-will-terminate-its-us-ads-program-2980757)
- 2022-03-14 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-effect-filed-by-biofrontera-ag-2565508)
- 2022-03-09 21:27 UTC [SEC Form 15F-12B filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-15f-12b-filed-by-biofrontera-ag-2549667)
- 2022-03-09 19:35 UTC [SEC Form POS AM filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-biofrontera-ag-2548699)
- 2022-03-09 19:29 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-biofrontera-ag-2548653)
- 2022-02-25 21:01 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Biofrontera AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-biofrontera-ag-amendment-2480931)
- 2022-02-24 21:05 UTC [SEC Form 25 filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-25-filed-by-biofrontera-ag-2471695)
- 2022-02-24 19:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2470445)
- 2022-02-23 13:15 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-2457589)
- 2022-02-22 15:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2450276)
- 2022-02-18 13:16 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-2440436)
- 2022-02-17 13:11 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-2433092)
- 2022-02-14 19:46 UTC [Market Chatter] [Biofrontera Shares Resume Trading, Move Higher](https://www.quantisnow.com/insight/biofrontera-shares-resume-trading-move-higher-2410969)
- 2022-02-14 19:41 UTC [Market Chatter] [Biofrontera Shares Halted On Circuit Breaker; Down 22%](https://www.quantisnow.com/insight/biofrontera-shares-halted-on-circuit-breaker-down-22-2410821)
- 2022-02-14 19:35 UTC [Market Chatter] [Biofrontera Shares Resume Trade, Down ~30%](https://www.quantisnow.com/insight/biofrontera-shares-resume-trade-down-30-2410640)
- 2022-02-14 19:20 UTC [Market Chatter] [Biofrontera Shares To Resume Trade At 2:35 p.m. EST](https://www.quantisnow.com/insight/biofrontera-shares-to-resume-trade-at-235-pm-est-2410461)
- 2022-02-14 19:05 UTC [Market Chatter] [Biofrontera To Delist Its ADS From Nasdaq](https://www.quantisnow.com/insight/biofrontera-to-delist-its-ads-from-nasdaq-2410239)
- 2022-02-14 19:05 UTC [Public Offering] [Biofrontera AG decides to delist ADS from Nasdaq to reduce complexity and costs](https://www.quantisnow.com/insight/biofrontera-ag-decides-to-delist-ads-from-nasdaq-to-reduce-2410229)
- 2022-02-14 19:00 UTC [Market Chatter] [Biofrontera Shares Halted On Code News Pending](https://www.quantisnow.com/insight/biofrontera-shares-halted-on-code-news-pending-2410178)
- 2022-02-09 17:46 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-2380312)
- 2022-02-09 13:14 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-2377242)
- 2022-02-01 15:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2333472)
- 2022-01-25 15:44 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-2296423)
- 2022-01-13 14:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2251254)
- 2021-12-30 13:47 UTC [Market Chatter] [UPDATE: Biofrontera Is No Longer Considered A Subsidiary Of Biofrontera AG](https://www.quantisnow.com/insight/update-biofrontera-is-no-longer-considered-a-subsidiary-of-biofrontera-2195101)
- 2021-12-30 13:45 UTC [Market Chatter] [Biofrontera Announces Reduction Of Biofrontera AG Shareholding To Less Than 50% Through Warrant Exercises](https://www.quantisnow.com/insight/biofrontera-announces-reduction-of-biofrontera-ag-shareholding-to-less-than-2195094)
- 2021-12-29 11:20 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2190197)
- 2021-12-21 21:01 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Biofrontera AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-biofrontera-ag-amendment-2171108)
- 2021-12-17 17:42 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-2157967)
- 2021-12-15 18:46 UTC [Market Insight] [Biofrontera Shares Are Trading Higher After Benchmark Initiates Coverage](https://www.quantisnow.com/insight/biofrontera-shares-are-trading-higher-after-benchmark-initiates-coverage-2145757)
- 2021-12-14 19:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2138959)
- 2021-12-13 15:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2131136)
- 2021-12-13 14:14 UTC [Market Insight] [Biofrontera AG Enrolls First Patient To Phase IIb Clinical Study Evaluating Ameluz / BF-RhodoLED For Acne](https://www.quantisnow.com/insight/biofrontera-ag-enrolls-first-patient-to-phase-iib-clinical-study-2130581)
- 2021-12-08 14:34 UTC [Market Chatter] [Biofrontera Announces Notice Of Allowance For U.S. Method-of-Use Patent On PDT-Lamp. BZ NOTE: Benzinga Reported This Patent On Dec. 2](https://www.quantisnow.com/insight/biofrontera-announces-notice-of-allowance-for-us-method-of-use-patent-on-2112958)
- 2021-12-08 13:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2112310)
- 2021-12-06 14:03 UTC [Market Insight] [Biofrontera Inc. Enrolls First Subject In Phase 1 Safety Study Evaluating Photodynamic Therapy With Three Tubes Of Ameluz](https://www.quantisnow.com/insight/biofrontera-inc-enrolls-first-subject-in-phase-1-safety-study-2100079)
- 2021-12-06 11:54 UTC [Market Insight] [Biofrontera AG Announced Eenrollment of First Patient in Phase I Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz](https://www.quantisnow.com/insight/biofrontera-ag-announced-eenrollment-of-first-patient-in-phase-i-2098511)
- 2021-12-02 15:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2087927)
- 2021-12-02 14:16 UTC [Market Chatter] [Biofrontera Announces Notice Of Allowance For U.S. Patent Titled 'Illumination for Photodynamic Therapy'](https://www.quantisnow.com/insight/biofrontera-announces-notice-of-allowance-for-us-patent-titled-illumination-2087525)
- 2021-12-02 12:37 UTC [SEC Form 6-K] [SEC Form 6-K filed by Biofrontera AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-biofrontera-ag-2086326)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BFRA
- Earnings history: https://www.quantisnow.com/earnings/BFRA
- Dividend history: https://www.quantisnow.com/dividends/BFRA
- Insider transactions: https://www.quantisnow.com/insiders/BFRA
- Options chain: https://www.quantisnow.com/options/BFRA
- SEC 8-K filings only: https://www.quantisnow.com/company/BFRA/8-k
- RSS and alerts for BFRA: https://www.quantisnow.com/docs/rss-feeds.md
